ADMA Biologics
ADMA
ADMA
56 hedge funds and large institutions have $84.5M invested in ADMA Biologics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.18% less ownership
Funds ownership: 53.28% → 48.1% (-5.2%)
84% less call options, than puts
Call options by funds: $297K | Put options by funds: $1.81M
Holders
56
Holding in Top 10
1
Calls
$297K
Puts
$1.81M
Top Buyers
| 1 | +$1.28M | |
| 2 | +$853K | |
| 3 | +$663K | |
| 4 |
Barclays
London,
United Kingdom
|
+$210K |
| 5 |
Jane Street
New York
|
+$177K |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$1.23M | |
| 3 | -$205K | |
| 4 |
Morgan Stanley
New York
|
-$96.9K |
| 5 |
JP Morgan Chase
New York
|
-$90.8K |